Already FDA-approved to treat major depression and migraines, TMS can now be marketed as a treatment for obsessive compulsive disorder Santa Barbara, Calif., September 21, 2018 – Transcranial Magnetic Stimulation (TMS) therapy is rapidly growing in popularity as a treatment [..]
Defined as continuous pain that last six months or more, chronic pain affects roughly 100 million Americans. Chronic pain can range from mild but consistent soreness or tightness to severe pain that may be described as shooting, burning, aching or electrical. Often, but not always, the cause of chronic pain is an injury or infection that seemingly heals but the pain remains in the nervous system plaguing the patient sometimes for years. Patients suffering with pain of this nature and duration experience both physical and emotional impacts. TheraMind specializes in addressing these adverse impacts by stimulating the brain’s neuroplasticity using the most advanced diagnostic and therapeutic technologies available today. Our goal is to eliminate or substantially reduce decrease the intensity and duration of the pain a patient suffers and to accomplish this end in the least invasive, non-drug manner possible.
Clinical studies of the application of neurotherapy, including transcranial magnetic stimulation (TMS), with chronic pain sufferers suggest that this technology can be very effective. In fact, a single session of TMS can reduce the detection of pain as found by Johnson, Summers and Pridmore. Click here to read more about this ground breaking study. In a summary of a study headed by Dr. Frengi on non-invasive brain stimulation for the treatment of pain the authors optimistically predict that rTMS and tDCS might become new therapeutic options for patients with chronic pain. To read more click here. If you or someone you know is suffering from chronic pain, we would be happy to talk more about your treatment options. Call us today to learn more.